OTC Pharmaceuticals - Netherlands

The revenue in the OTC Pharmaceuticals market in the Netherlands is projected to amount to US$1.11bn in 2024.
This market is expected to grow annually by 3.28% (CAGR 2024-2029).
The largest market within this industry is Cold & Cough Remedies, which is estimated to have a market volume of US$235.80m in 2024.
When compared globally, the United States generates the highest revenue, reaching US$41.24bn in 2024.
In terms of per capita figures, in the Netherlands generates US$62.74 in revenue per person in 2024.
Furthermore, it is projected that 28.21% of the total revenue in the OTC Pharmaceuticals market will be generated through online sales by 2024.
The Netherlands has seen a rise in demand for OTC pharmaceuticals as consumers increasingly seek self-care options.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in the Netherlands has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.Customer preferences in the Netherlands have shifted towards self-care and self-medication. Consumers are increasingly seeking convenience and accessibility in their healthcare choices. They prefer to have the option of purchasing medications without a prescription, allowing them to treat minor ailments and manage their health independently. This preference for self-care has fueled the demand for over-the-counter (OTC) pharmaceuticals in the country.Trends in the market reflect the changing dynamics of the healthcare industry in the Netherlands. The aging population and the increasing prevalence of chronic diseases have led to a greater focus on preventive healthcare and the management of long-term conditions. OTC pharmaceuticals play a crucial role in this context, as they provide individuals with the means to address common health issues and maintain their well-being. As a result, the market for OTC pharmaceuticals has expanded to include a wide range of products, from pain relievers and cold remedies to vitamins and dietary supplements.Local special circumstances in the Netherlands have also contributed to the growth of the OTC Pharmaceuticals market. The country has a well-developed healthcare system that emphasizes patient empowerment and self-management. The government has implemented policies to encourage self-care and reduce the burden on primary healthcare providers. This has created a favorable environment for the sale and consumption of OTC pharmaceuticals.Underlying macroeconomic factors have further supported the development of the OTC Pharmaceuticals market in the Netherlands. The country has a strong economy and a high standard of living, which enables consumers to afford healthcare products and services. Additionally, the Netherlands has a well-established retail sector, with a wide network of pharmacies, drugstores, and supermarkets that offer OTC pharmaceuticals. This accessibility has made it easier for consumers to purchase these products and has contributed to the overall growth of the market.In conclusion, the OTC Pharmaceuticals market in the Netherlands has experienced growth due to customer preferences for self-care, trends in the healthcare industry, local special circumstances, and underlying macroeconomic factors. As consumers continue to prioritize convenience and accessibility in their healthcare choices, the demand for OTC pharmaceuticals is expected to remain strong in the country.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.